Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia.
Urinary cholesterol was determined in follow-up in 2 patients with prostatic adenoma, 3 patients with prostatic carcinoma, 3 patients with carcinoma of bladder, and 4 patients with carcinoma of kidney. All patients revealed marked urinary cholesterol hyperexcretion prior to surgery. Except for 1 patient with prostatic carcinoma, excretion of urinary cholesterol normalized at least six weeks after resection. In 1 remarkable case a localized recurrence of a transurethrally resected bladder tumor was associated with a marked increase of urinary cholesterol excretion six weeks prior to cystoscopy. The results point to a possible future value of this method in monitoring patients with bladder tumors, although additional studies are necessary.
D000368:Aged; D002784:Cholesterol / Q000652:urine*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000652:urine*; D011471:Prostatic Neoplasms / Q000652:urine; D001749:Urinary Bladder Neoplasms / Q000652:urine; D014565:Urogenital Neoplasms / Q000652:urine*
D002784:Cholesterol